Dr. David Greenberg, MD

Claim this profile

Saint Louis University

Studies Giant Cell Tumor
Studies Recurrence
1 reported clinical trial
1 drug studied

Affiliated Hospitals

Image of trial facility.
Saint Louis University

Clinical Trials David Greenberg, MD is currently running

More about David Greenberg, MD

Clinical Trial Related6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments David Greenberg, MD has experience with
  • Zoledronic Acid

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Greenberg, MD specialize in?
David Greenberg, MD focuses on Giant Cell Tumor and Recurrence. In particular, much of their work with Giant Cell Tumor has involved treating patients, or patients who are undergoing treatment.
Is David Greenberg, MD currently recruiting for clinical trials?
Yes, David Greenberg, MD is currently recruiting for 1 clinical trial in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that David Greenberg, MD has studied deeply?
Yes, David Greenberg, MD has studied treatments such as Zoledronic Acid.
What is the best way to schedule an appointment with David Greenberg, MD?
Apply for one of the trials that David Greenberg, MD is conducting.
What is the office address of David Greenberg, MD?
The office of David Greenberg, MD is located at: Saint Louis University, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Saint Louis University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.